Varun Chopra, DPM
Podiatrist · Denver, CONPI 1639564511
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,200 of the $9,773 with a category attached, or 73.7%. Gemini Mountain Medical, LLC accounts for 68.3% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $7,057 and has fallen 94.7% since, to $377 in 2025.
Across 65 payments — averaging $150.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gemini Mountain Medical, LLC$7K
- Arthrex$2K
- Smith+Nephew$202
- Treace Medical Concepts, Inc.$162
- SPR Therapeutics, Inc$125
- Amgen$124
- plus $862 from 25 others
What the payments were for
- Travel & lodging$99210%
- Food & beverage$1,58116%
- Education$7,20074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gemini Mountain Medical, LLC | 7 | $6,679 |
| Arthrex | 6 | $1,618 |
| Smith+Nephew | 6 | $202 |
| Treace Medical Concepts, Inc. | 3 | $162 |
| SPR Therapeutics, Inc | 1 | $125 |
| Amgen(2 entities) | 6 | $124 |
| Stryker | 1 | $104 |
| Vilex LLC | 1 | $82 |
| Averitas Pharma Inc. | 3 | $70 |
| Kerecis Limited | 3 | $61 |
| Acumed LLC | 2 | $54 |
| Bioventus LLC | 3 | $52 |
| DJO, LLC | 1 | $45 |
| Pacira Pharmaceuticals Incorporated | 1 | $42 |
| AbbVie | 2 | $41 |
| Orthofix Medical, Inc. | 3 | $40 |
| Johnson & Johnson | 2 | $32 |
| Mimedx Group, Inc. | 1 | $30 |
| Zimmer Biomet | 1 | $24 |
| Vertex | 1 | $20 |
| Aroa Biosurgery Incorporated | 1 | $20 |
| Ossur Americas, Inc. | 1 | $17 |
| Paragon 28, Inc. | 1 | $17 |
| Lifenet Health | 1 | $15 |
| Biocomposites Inc | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Biotissue Holdings Inc. | 1 | $14 |
| Curonix LLC | 1 | $14 |
| Access Pro Medical, LLC | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$125
- Santyl$122
- REGRANEX$122
- Oasis$122
- ICONIX$104
How this compares
$9,773 in reported general payments places this provider in the 85th percentile of 70 podiatrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 18 | $315 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Denver
- Amber KavanaghDenver$20K
- Kenneth MorganDenver$20K
- Andrea BatraDenver$12K
- Eric HillmannDenver$9K
- Kevin NguyenDenver$9K
- Oliver KnauerDenver$7K
- Christopher ScottenDenver$7K
- Olivia AlloreDenver$4K
- Angela TebaldiDenver$3K
- Eugene RosenthallDenver$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.